This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Sosuke Yoneda: Innovator in Monoclonal Antibody Development
Introduction
Sosuke Yoneda is a prominent inventor based in Toyonaka, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work aims to address critical medical challenges, including pain management.
Latest Patents
Sosuke Yoneda holds a patent for a monoclonal antibody against Nav1.7. The objective of this invention is to provide a novel monoclonal antibody that can be utilized for treating or preventing pain and pruritus. The patent discloses a monoclonal antibody or its antibody fragment, characterized by specific six CDRs (CDR1 to CDR3 of a heavy chain and CDR1 to CDR3 of a light chain) or specific heavy/light chain variable regions. This advancement has the potential to significantly impact therapeutic approaches in pain management.
Career Highlights
Sosuke Yoneda is associated with Shionogi Company Limited, where he continues to innovate and contribute to the field of medical research. His work is recognized for its potential to improve patient outcomes through advanced therapeutic solutions.
Collaborations
He collaborates with notable colleagues, including Mai Yoshikawa and Etsuo Nakamura, who share his commitment to advancing medical science through innovative research.
Conclusion
Sosuke Yoneda's contributions to the development of monoclonal antibodies represent a significant advancement in biotechnology. His work not only showcases his inventive spirit but also holds promise for improving the quality of life for patients suffering from pain and related conditions.